📣If you are a clinician who has to anti-coagulate patients with liver disease, then these articles are a must-read!
Elsevier Hematology #liverdisease #anticoagulation #warfarin #DOAC

Bleeding is the most dreaded complication of anticoagulant therapy.

This narrative review outlines a pragmatic multimodal framework for severe DOAC bleed management with case examples Deborah Siegal

Read more here: sciencedirect.com/science/articl…

Elsevier Hematology
#ThrJournal #Bleeding

New #RPTHOriginalArticle shows that Caffeic acid (CA) plays important role in hemostasis. Platelet #RNAseq reveals that CA regulates hemostasis and #platelet activation-related potential target pathways and genes to promote #hemostasis . Elsevier Hematology
✅ rpthjournal.org/article/S2475-…

Sincere and enduring thanks to the reviewers for their generosity and support to Thrombosis Update in assisting the journal with peer review in the year 2023
Lucy NORRIS and Emmanouil Papadakis
Elsevier Hematology #ThrJournal

sciencedirect.com/science/articl…

A narrative review of the current literature and guidelines, the risks and benefits of alternative therapy options on outcomes for the optimal management of intermediate-high risk #PE

@bibibassa Elizabeth Little Leah Flanagan

sciencedirect.com/science/articl…

#ThrJournal Elsevier Hematology

Read the obituary published in EXPHEM to honor the former EIC - Remembering Professor Connie Eaves: an exceptional researcher, mentor and friend ISEH.
spkl.io/60104F1fg

New research online from Thrombosis Research

In NVAF patients with liver disease, DOACs were as effective and slightly safer than VKAs, and apixaban was as effective and safer than rivaroxaban

Learn more: spkl.io/601440NXn

The Editors of Blood Advances invite you to explore widely read articles recently published in the journal. Read the Editors’ Choice collection here: spkl.io/601740rNJ

@ASH_Hematology

Explore the Editors’ Choice collection from Blood Journal to discover valuable insights into some of the most challenging hematological disorders spkl.io/601240r24

@ASH_Hematology

Discover thetop articles published in Research and Practice in Thrombosis and Haemostasis in 2023! spkl.io/60164xzWM RPTH

Read the Editors’ Choice collection from Blood Advances to discover key research published in the journal in 2023: spkl.io/601440rFK

@ASH_Hematology

The Editors of Blood Journal invite you to explore key articles published in the journal in 2023. Read the Editors' Choice collection here: spkl.io/601040r0m

@ASH_Hematology

New research online from Thrombosis Research

Anticoagulation in cancer patients with atrial fibrillation and grade 3–4 thrombocytopenia

Read now: spkl.io/60154Ihwx

See the most popular articles published in Experimental Hematology in 2023!
spkl.io/60124xzQ2
ISEH

Learn more about this recently published article from Leukemia Research Reports

Is Bartonella sp. infection relevant in hematological malignancies in HIV-negative patients? A literature review

Read now: spkl.io/60164IhdE

Learn more about the below article published in Cytotherapy

Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing

Read now: spkl.io/60144Ihig

New research online from Thrombosis Research

External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

Read now: spkl.io/60184Ihb6

Check out this recent review article from Cytotherapy

The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer

Read now: spkl.io/60114Ih5N

Learn more about this recently published article from Leukemia Research Reports

Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD

Read now: spkl.io/60194Ih5S

New research online from Leukemia Research Reports

Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion presenting with leonine facies

Read now: spkl.io/60124Ih5Y